Detalles de la búsqueda
1.
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Biol Blood Marrow Transplant
; 23(3): 428-435, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28039078
2.
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.
Blood
; 123(19): 2953-9, 2014 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24652994
3.
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Am J Hematol
; 85(4): 261-3, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20201088
4.
Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma?
Virchows Arch
; 453(4): 407-11, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18696109
5.
Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.
Haematologica
; 92(1): 139-40, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17229653
6.
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.
J Antimicrob Chemother
; 59(4): 711-7, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17327294
Resultados
1 -
6
de 6
1
Próxima >
>>